细胞培养基市场规模、份额及成长分析(依产品、应用、培养基类型、最终用途及地区划分)-2026-2033年产业预测
市场调查报告书
商品编码
1897361

细胞培养基市场规模、份额及成长分析(依产品、应用、培养基类型、最终用途及地区划分)-2026-2033年产业预测

Cell Culture Media Market Size, Share, and Growth Analysis, By Product (Serum-free Media, Classical Media), By Application (Biopharmaceutical Production, Drug Screening and Development), By Media Type, By End Use, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 213 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球细胞培养基市场规模预计在 2024 年达到 62.3 亿美元,从 2025 年的 72.3 亿美元增长到 2033 年的 237.3 亿美元,在预测期(2026-2033 年)内复合年增长率为 16.02%。

全球细胞培养基市场正经历显着成长,这主要得益于各行业对招募自动化解决方案的日益普及。企业和政府机构正越来越多地采用整合式机器学习和人工智慧的先进系统来提高招募效率。这些解决方案利用自然语言处理和数据分析来简化筛选流程,有效减少人工筛选中常见的错误和偏见。申请人追踪系统 (ATS) 的需求不断增长,其优势在于能够更快、更准确地处理申请,同时降低人事费用。银行、医疗保健、製造业和电信等行业正在利用这些创新工具来改善人才招聘,这凸显了劳动力管理自动化更广泛的趋势。

全球细胞培养基市场驱动因素

全球细胞培养基市场的发展主要得益于研究人员不断创新,致力于提升细胞培养基在各种临床应用中的效能。白蛋白是生产必需单株抗体和重组蛋白的关键成分,它在结合和稳定重要小分子和离子方面发挥着至关重要的作用,从而确保生产过程的稳定性。因此,在培养基中添加重组哺乳动物白蛋白有望显着推动市场成长并提高产品产量。未来,采用此类先进调查方法可望进一步促进市场扩张。

全球细胞培养基市场面临的限制因素

全球细胞培养基市场面临严峻挑战,尤其是在中低收入国家,品管系统的不足尤为突出。这些地区资源匮乏,难以妥善储存和维护细胞培养基,迫使其依赖可能无法满足严格品质标准的简易设备。这种情况往往导致污染水平升高,从而损害培养基的整体品质和可靠性。因此,先进设备和高效流程的匮乏对细胞培养的有效性产生了负面影响,并成为限制该细分市场成长和发展的重大阻碍因素。

全球细胞培养基市场趋势

受基因疗法的广泛应用和发展所推动,全球细胞培养基市场正经历显着成长。随着基因疗法在治疗多种获得性和遗传性神经系统疾病的应用日益普及,用于支持基因产物开发和生产的专用培养基需求激增,这些基因产物能够缓解细胞功能障碍。全球持续进行的基因疗法新应用研发工作预计将进一步推动对高品质细胞培养基的需求,这反映了生命科学领域向创新疗法发展的整体趋势。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 监管分析

全球细胞培养基市场规模(按产品和复合年增长率划分)(2026-2033 年)

  • 无血清培养基
    • CHO培养基
    • BHK 中等
    • Vero 中等
    • HEK 293 中等大小
    • 其他无血清培养基
  • 传统媒体
  • 干细胞培养基
  • 特殊培养基
  • 化学成分明确的培养基
  • 其他细胞培养基

全球细胞培养基市场规模(依应用及复合年增长率划分)(2026-2033 年)

  • 生物製药生产
    • 单株抗体
    • 疫苗生产
    • 其他治疗性蛋白质
    • 诊断
  • 药物筛检与开发
  • 组织工程与再生医学
    • 细胞和基因治疗
    • 其他组织工程及再生医学应用
  • 其他用途

全球细胞培养基市场规模(按培养基类型和复合年增长率划分)(2026-2033 年)

  • 液体介质
  • 半固态和固态介质

全球细胞培养基市场规模(按最终用途和复合年增长率划分)(2026-2033 年)

  • 製药和生物技术公司
  • 医院和诊断检查室
  • 研究和学术机构
  • 其他用途

全球细胞培养基市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Thermo Fisher Scientific Inc.(USA)
  • Merck KGaA(Germany)
  • Cytiva(USA)
  • Lonza Group Ltd.(Switzerland)
  • Sartorius AG(Germany)
  • Fujifilm Irvine Scientific, Inc.(USA)
  • Corning Incorporated(USA)
  • Bio-Techne Corporation(USA)
  • PromoCell GmbH(Germany)
  • CellGenix GmbH(Germany)
  • Takara Bio Inc.(Japan)
  • HiMedia Laboratories Pvt. Ltd.(India)
  • Zenbio, Inc.(USA)
  • Biological Industries(Israel)
  • Cook Medical(USA)
  • Stemcell Technologies Inc.(Canada)
  • Serumwerk Bernburg AG(Germany)
  • AthenaES(USA)
  • Biochrom GmbH(Germany)
  • Pan-Biotech GmbH(Germany)

结论与建议

简介目录
Product Code: SQMIG35H2057

Global Cell Culture Media Market size was valued at USD 6.23 Billion in 2024 and is poised to grow from USD 7.23 Billion in 2025 to USD 23.73 Billion by 2033, growing at a CAGR of 16.02% during the forecast period (2026-2033).

The Global Cell Culture Media market is witnessing significant growth driven by the increasing adoption of recruitment automation solutions across various sectors. Businesses and government entities are turning to advanced systems that integrate machine learning and artificial intelligence to enhance hiring efficiency. These solutions streamline the screening process by utilizing natural language processing and data analytics, effectively reducing human error and bias often present in manual reviews. The demand for applicant tracking systems (ATS) is rising, as they facilitate faster and more accurate processing of applications while simultaneously lowering labor costs. Industries including banking, healthcare, manufacturing, and telecommunications are leveraging these innovative tools to improve talent acquisition, highlighting a broader trend towards automation in workforce management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Culture Media Market Segments Analysis

Global Cell Culture Media Market is segmented by Product, Application, Media Type, End Use and region. Based on Product, the market is segmented into Serum-free Media, Classical Media, Stem Cell Culture Media, Specialty Media, Chemically Defined Media and Other Cell Culture Media. Based on Application, the market is segmented into Biopharmaceutical Production, Drug Screening and Development, Tissue Engineering andRegenerative Medicineand Other Applications. Based on Media Type, the market is segmented into Liquid Media and Semi-solid and Solid Media. Based on End Use, the market is segmented into Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes and Other End Uses. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Culture Media Market

The Global Cell Culture Media market is fueled by the ongoing innovative efforts of researchers striving to enhance the effectiveness of cell culture media for various clinical applications. A critical component in the production of essential monoclonal antibodies and recombinant proteins is albumin, which plays a pivotal role in binding and stabilizing vital small molecules and ions, ensuring stability in manufacturing processes. Consequently, the integration of recombinant mammalian albumin supplements into culture media is expected to significantly drive market growth and improve product yields. The adoption of these advanced methodologies is likely to further propel the expansion of the market moving forward.

Restraints in the Global Cell Culture Media Market

The Global Cell Culture Media market faces significant challenges stemming from the inadequacies in quality management systems, particularly in low and middle-income countries. In these regions, resource limitations hinder the proper storage and maintenance of cell culture media, resulting in reliance on basic instruments that may not meet rigorous quality standards. This situation often leads to increased contamination levels, compromising the overall quality and reliability of the culture media. Consequently, the lack of advanced equipment and efficient processes has a detrimental impact on the effectiveness of cell culture practices, highlighting a critical restraint in the growth and advancement of this market segment.

Market Trends of the Global Cell Culture Media Market

The global cell culture media market is witnessing significant growth driven by the increasing acceptance and advancements in gene therapies. As gene therapies become more prevalent for treating a broad spectrum of acquired and inherited neurological disorders, the need for specialized cell culture media has surged to support the development and production of gene products that mitigate cellular dysfunction. With ongoing global research and development efforts aimed at discovering novel applications for gene therapy, the demand for high-quality cell culture media is poised to expand, reflecting the overall trend toward innovative therapeutic approaches in the life sciences sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Analysis

Global Cell Culture Media Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Serum-free Media
    • CHO Media
    • BHK Medium
    • Vero Medium
    • HEK 293 Media
    • Other Serum-free media
  • Classical Media
  • Stem Cell Culture Media
  • Specialty Media
  • Chemically Defined Media
  • Other Cell Culture Media

Global Cell Culture Media Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Biopharmaceutical Production
    • Monoclonal Antibodies
    • Vaccines Production
    • Other Therapeutic Proteins
    • Diagnostics
  • Drug Screening and Development
  • Tissue Engineering and Regenerative Medicine
    • Cell and Gene Therapy
    • Other tissue engineering and regenerative medicine applications
  • Other Applications

Global Cell Culture Media Market Size by Media Type & CAGR (2026-2033)

  • Market Overview
  • Liquid Media
  • Semi-solid and Solid Media

Global Cell Culture Media Market Size by End Use & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Research and Academic Institutes
  • Other End Uses

Global Cell Culture Media Market Size & CAGR (2026-2033)

  • North America (Product, Application, Media Type, End Use)
    • US
    • Canada
  • Europe (Product, Application, Media Type, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, Media Type, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, Media Type, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, Media Type, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cytiva (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Irvine Scientific, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PromoCell GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CellGenix GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zenbio, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biological Industries (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stemcell Technologies Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Serumwerk Bernburg AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AthenaES (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biochrom GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pan-Biotech GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations